EXTH-23. COMBINED EFFECTS OF NICLOSAMIDE AND TEMOZOLOMIDE AGAINST HUMAN GLIOBLASTOMA TUMORSPHERES

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Cheol Oh, Hyeong, Yoo, Jihwan, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-hyun, Joo Choi, Ran, sil Kim, Hyun, hee Kim, Nam, Hyung Moon, Ju, Hyun Kim, Eui, Hee Chang, Jong, Kang, Seok-Gu, In Yook, Jong
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847496/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.357
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky